IntegrateRNA Launches Aminoacyl-tRNA Synthesis Service for Custom Protein Engineering

By Yonkers Editorial Team
Creative Biogene's IntegrateRNA division has launched an in vitro service to produce customized aminoacylated tRNAs, enabling protein synthesis with non-canonical amino acids for advanced therapeutics and industrial enzymes.
IntegrateRNA Launches Aminoacyl-tRNA Synthesis Service for Custom Protein Engineering

IntegrateRNA, the R&D focused business division of Creative Biogene, has launched a new Aminoacyl-tRNA In Vitro Synthesis Service designed to support protein synthesis research by enabling the generation of customized aminoacylated tRNAs. These molecules are essential for robust protein translation in in vitro systems, allowing for more accurate and scalable production of proteins containing non-canonical amino acids.

The service utilizes a robust in vitro translation system to covalently link amino acids to transfer RNA molecules through an enzyme-based process that mimics natural cellular translation. This technology enables high-yield production of aminoacylated tRNAs and supports the inclusion of non-canonical or modified amino acids, expanding the design possibilities for researchers. Scientists can now design and produce custom proteins with enhanced stability, activity, or specificity, with potential applications in developing new therapeutics and industrial enzymes.

Marcia Brady, Head of Technology at Creative Biogene, emphasized the transformative nature of this development, stating that synthesizing proteins with non-canonical amino acids opens new possibilities for designing proteins with specific properties and could significantly accelerate biotechnology development. The service is anticipated to find applications across pharmaceutical R&D, protein engineering, and novel biologics development, particularly in creating protein variants with unique properties not achievable through natural processes alone.

Future plans for IntegrateRNA include improving the Aminoacyl-tRNA synthesis platform to support an even broader array of amino acid modifications and expanding production to industrial scale. These advancements could have major impacts on synthetic biology and therapeutic protein development, potentially leading to next-generation biopharmaceuticals and engineered enzymes. The service represents a significant step forward in protein engineering capabilities, providing researchers with tools to engineer proteins with improved functional characteristics across multiple scientific disciplines.

Yonkers Editorial Team

Yonkers Editorial Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.